Horizon Capital, a U.S. private-equity firm investing in high growth companies in Ukraine and the near region, and Dobrobut, the leading private healthcare services provider in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in Dobrobut. Financial details for this transaction have not been disclosed.
Horizon Capital, a U.S. private-equity firm investing in high growth export-oriented and domestic companies in Ukraine and the near region, and Ajax Systems, a leading producer of smart security systems in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in the Company for $10 million.
Horizon Capital, a U.S. private-equity firm investing in high growth and export-driven companies in Ukraine and the near region, has closed its third fund, Emerging Europe Growth Fund III, L.P. (“EEGF III”, the “Fund”), at its $200 million hard cap, far surpassing the $150 million target. In what marks the largest private equity fund raised for Ukraine in a decade, Horizon’s EEGF III received strong backing from existing and new investors, attracted by the excellent value, fast growth and abundance of opportunities that Ukraine offers. Led by Founding Partners Lenna Koszarny and Jeffrey C. Neal and Senior Partner Denis Tafintsev, Horizon manages over $850 million in assets from investors with a capital base exceeding $350 billion. Its Ukraine-focused funds have invested over $650 million in 140 companies employing over 46,000 people.
Rozetka, the leading online e-commerce retailer in Ukraine and EVO, the internet company behind the country’s largest marketplace Prom.ua, have completed a merger, cementing their top position in Ukraine’s fast-growing e-commerce segment of the retail market.
Horizon Capital announced today the exit of its full stake in Ergopack, a leading Ukrainian manufacturer of household goods, to Sarantis, a European strategic investor and leading publicly-listed consumer goods company.
Horizon Capital, a leading private equity firm in the region, announced today that Purcari Wineries PLC (Purcari) has completed its Initial Public Offering and commenced trading on the Bucharest Stock Exchange (BSE: WINE). The offering was well received, with retail investors oversubscribing more than four times over, despite heavy turbulence on global markets as the Dow recorded its two largest point-drops on record. As a result of this successful public launch, Horizon Capital, on behalf of its fund EEGF II, has sold a 40.9% stake in Purcari, realizing a 3.2 times gross cash-on-cash return on the sale of these shares. Horizon Capital remains an active shareholder with a 22.7% stake held, aiming to further capitalize on the fast growth of the Company, as Purcari seeks to become the undisputed champion of the high-growth CEE wine market.
Horizon Capital announced today that it has increased its stake in Datagroup, a leading independent telecom operator in Ukraine, from significant minority to over 70%. Following completion of this transaction, Horizon Capital has assumed operational control of the company. The financial details of the transaction were not disclosed.
Ciklum Holding Limited announced today that the Ukrainian Redevelopment Fund LP will acquire a significant equity stake in Ciklum. The transaction is expected to be completed by the end of 2015, subject to customary closing conditions and regulatory approval. The Ukrainian Redevelopment Fund is acquiring the entire stake held by Horizon Capital and an undisclosed portion of the stake held by Majgaard Holdings Ltd.
Horizon Capital has developed and is pleased to share a comprehensive, data-rich report entitled “Ukraine 2015: A ground-floor opportunity at the EU’s frontier”.
This facility is the first greenfield pharmaceutical plant built in Ukraine, with investment of over $40 million, through a consortium of U.S-Dutch-Ukrainian investors including U.S. investment manager Horizon Capital, Dutch development finance bank FMO and Ukrainian shareholders. The new plant was designed by Linde (Germany), an international engineering company with extensive experience in the pharmaceutical industry, equipped with modern Italian machinery, is ISO9000 and ISO14001 certified and meets all current regulatory and GMP (Good Manufacturing Practice) requirements. The plant is the first and only Western investment of such scale in the Ukrainian pharmaceutical industry and the best-in-class facility of its kind in Central and Eastern Europe.